European Salk Institutes
29 years without Jonas Salk: against the normalization of the absurd
Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry
Public pharma infrastructure could give the world access to a treasure trove of medicines
Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers






